Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia

Fang, Li-ChingLi-ChingFangWang, Jen-YuJen-YuWangHSIN-HUI YULI-CHIEH WANGBOR-LUEN CHIANG2023-11-102023-11-102023-1127728293https://scholars.lib.ntu.edu.tw/handle/123456789/637101Infants with respiratory-syncytial virus bronchiolitis hospitalization are more likely to develop wheezing and subsequent asthma. Reportedly, palivizumab prophylaxis effectively prevents respiratory-syncytial virus hospitalization in high-risk children-such as premature infants or infants with bronchopulmonary dysplasia (BPD).enAsthma; RSV bronchiolitis; bronchopulmonary dysplasia; palivizumab; prematurity[SDGs]SDG3Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasiajournal article10.1016/j.jacig.2023.100161377816662-s2.0-85169038398https://api.elsevier.com/content/abstract/scopus_id/85169038398